Atlas Trials

A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma

Clinical trial NCT02512900 · COMPLETED

Trial details

NCT number
NCT02512900
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Asthma
Start date
2015-09-10
Primary completion
2016-05-17
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.